onizes Our Approach to Health page 345
September 2012
led to the development of induced pluripotent
stem cells (iPSCs). Unlike ESCs which are
politically encumbered and limited by the lack
of known information on the donors’ genetic and
disease background, iPSCs are developed from
reprogramming adult cells, like a standard doctor’s
office blood draw, into a pluripotent state, from
which they can then be transformed into any cell
